Ausgabe 2/2006
Inhalt (11 Artikel)
The reasons of general practitioners for promoting colorectal cancer mass screening in France
Célia Berchi, Jean-Marc Dupuis, Guy Launoy
Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer
Samuel Limat, Claire-Hélène Bracco-Nolin, Christine Legat-Fagnoni, Loic Chaigneau, Ulrich Stein, Bernard Huchet, Xavier Pivot, Marie-Christine Woronoff-Lemsi
The future of imaging techniques for cancer patients in The Netherlands
Theo J. B. M. Postma, Janneke C. Alers, Sijmon Terpstra, Arjan Zuurbier
Factors influencing the costs of emergency medical admissions to an Irish teaching hospital
Edward D. Moloney, Kathleen Bennett, Bernard Silke
Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers
Hans-Georg Eichler, Sheldon X. Kong, Jean-Pierre Grégoire
Cost-effectiveness of memantine in community-based Alzheimer’s disease patients: an adaptation in Spain
Fernando Antonanzas, Benoit Rive, Josep M. Badenas, Susana Gomez-Lus, Chantal Guilhaume
Costs of chemotherapy in the treatment of colorectal cancer
F. G. A. Jansman, M. J. Postma
A taxonomy of health utility assessment methods and the role for uncertainty analysis
Agota Szende, Caroline Schaefer